Loading...

Zimmer Biomet Holdings Inc
NYSE:ZBH

Watchlist Manager
Zimmer Biomet Holdings Inc Logo
Zimmer Biomet Holdings Inc
NYSE:ZBH
Watchlist
Price: 124.19 USD +2.31%
Updated: Dec 8, 2022

Intrinsic Value

The intrinsic value of one ZBH stock under the Base Case scenario is 123.12 USD. Compared to the current market price of 124.19 USD, Zimmer Biomet Holdings Inc is Overvalued by 1%.

The Intrinsic Value is calculated as the average of the two valuation methods:

ZBH Intrinsic Value
Base Case
123.12 USD
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Fundamental Analysis

ZBH Profitability Score
Profitability Due Diligence

Zimmer Biomet Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Low 3-Year Average ROE
Low 3-Year Average ROIC
Positive Net Income
Low ROE
50/100
Profitability
Score

Zimmer Biomet Holdings Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ZBH Solvency Score
Solvency Due Diligence

Zimmer Biomet Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Average Interest Coverage
Positive Net Debt
Average Altman Z-Score
Short-Term Liabilities
45/100
Solvency
Score

Zimmer Biomet Holdings Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Financials
Efficiency
70%
Gross Margin
15%
Operating Margin
4%
Net Margin
13%
FCF Margin
2%
ROE
5%
ROIC
Other

ZBH Capital Structure
Zimmer Biomet Holdings Inc

Market Capitalization 25.8B USD
Total Debt 5.1B USD
Minority Interest 0 USD
Preferred Equity 0 USD
Cash and Equivalents 545M USD
Short-Term Investments 0 USD
Enterprise Value 30.3B USD

Wall St
Price Targets

ZBH Price Targets Summary
Zimmer Biomet Holdings Inc

Wall Street analysts forecast ZBH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ZBH is 125.95 USD with a low forecast of 101 USD and a high forecast of 152.25 USD.

Lowest
Price Target
101 USD
19% Downside
Average
Price Target
125.95 USD
1% Upside
Highest
Price Target
152.25 USD
23% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

ZBH Competitors
Zimmer Biomet Holdings Inc

ZBH Suppliers & Customers
Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc has 19 key suppliers from 10 countries and 8 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Technology industry.

Zimmer Biomet Holdings Inc has 6 key customers from 3 countries and 3 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Health Care industry.

Ownership

ZBH Insider Trading
Buy and sell transactions by insiders

Zimmer Biomet Holdings Inc insiders have only sold shares in the past 12 months.

During the last 12 months Zimmer Biomet Holdings Inc insiders have not bought any shares, and sold 4.7M USD worth of shares. The last transaction was made on Dec 8, 2022 by Van Zuilen Wilfred (Pres, Europe, M. East & Africa), who sold 55.9k USD worth of ZBH shares.

Sold
0-3
months
0 USD
0
3-6
months
55.9k USD
1
6-9
months
4.3M USD
1
9-12
months
358k USD
1
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
0
0 USD
6-9
months
0
0 USD
9-12
months
0
0 USD
Cumulative Transactions Amount
Period Sold Bought Net
3 Months
N/A
N/A
N/A
6 Months
55.9k USD
N/A
-55.9k
9 Months
4.3M USD
N/A
-4.3M
12 Months
4.7M USD
N/A
-4.7M
Purchases
21
Sales
206
Why is insider trading important?

Shareholder Return

ZBH Price
Zimmer Biomet Holdings Inc

1M 1M
+17%
6M 6M
+5%
1Y 1Y
+3%
3Y 3Y
-8%
5Y 5Y
+21%
Annual Price Range
124.19
52w Low
101.65
52w High
133.55
Price Metrics
Average Annual Return 10.83%
Standard Deviation of Annual Returns 26.63%
Max Drawdown -50%
Shares Statistics
Market Capitalization 25.8B USD
Shares Outstanding 209 820 000
Percentage of Shares Shorted 1.2%

Company Profile

Zimmer Biomet Holdings Inc

Country

United States of America

Industry

Health Care

Market Cap

25.8B USD

Dividend Yield

0.78%

Description

Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The company is headquartered in Warsaw Indiana, Indiana and currently employs 19,500 full-time employees. The company went IPO on 2001-07-25. The firm is engaged in the design, manufacture and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, craniomaxillofacial and thoracic (CMFT) products; dental implants, and related surgical products. The firm's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The company operates through four segments: Americas Orthopedics, Europe, Middle East and Africa (EMEA), Asia Pacific, and Americas Spine and Global Dental. Its knee brands include Persona Knee, NexGen Knee Implants, Vanguard Knee and Oxford Partial Knee. Its hip brands include Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System and G7 Acetabular System. Its S.E.T. brands include JuggerKnot Soft Anchor System, Gel-One1 Cross-linked Hyaluronate, Comprehensive Shoulder and others.

Contact

INDIANA
Warsaw Indiana
345 E Main St
+15742676131.0
https://www.zimmerbiomet.com/en

IPO

2001-07-25

Employees

19 500

Officers

Chairman, Pres & CEO
Mr. Bryan C. Hanson
Exec. VP & CFO
Mr. Suketu P. Upadhyay
Chief Operating Officer
Mr. Ivan Tornos
Group Pres of Asia Pacific
Mr. Sang Yi
Pres of Europe, Middle East & Africa
Mr. Wilfred van Zuilen
VP, Controller & Chief Accounting Officer
Mr. Paul A. Stellato
Show More
Chief Science, Technology & Innovation Officer
Dr. Nitin Goyal M.D.
Sr. VP & Chief Information Officer
Mr. Zeeshan Tariq
Chief Communications & Admin. Officer and Sr. VP of Investor Relations
Ms. Keri P. Mattox
Sr. VP, Gen. Counsel & Sec.
Mr. Chad F. Phipps
Show Less

See Also

Similar Stocks
What is the Intrinsic Value of one ZBH stock?

The intrinsic value of one ZBH stock under the Base Case scenario is 123.12 USD.

Is ZBH stock undervalued or overvalued?

Compared to the current market price of 124.19 USD, Zimmer Biomet Holdings Inc is Overvalued by 1%.